tradingkey.logo
搜索

Co-Diagnostics Inc

CODX
添加自选
1.440USD
-0.120-7.69%
收盘 07-31 16:00美东报价延迟15分钟
5.19M总市值
亏损市盈率 TTM

关于 Co-Diagnostics Inc 公司

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Co-Diagnostics Inc简介

公司代码CODX
公司名称Co-Diagnostics Inc
上市日期Jul 12, 2017
CEOEgan (Dwight H)
员工数量132
证券类型Ordinary Share
年结日Jul 12
公司地址2401 S. Foothill Dr. Suite D
城市SALT LAKE CITY
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编84109
电话18014381036
网址https://codiagnostics.com/
公司代码CODX
上市日期Jul 12, 2017
CEOEgan (Dwight H)

Co-Diagnostics Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
12.45K
+13.62%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
12.36K
+13.71%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Richard Abbott
Mr. Richard Abbott
President
President
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
12.45K
+13.62%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
12.36K
+13.71%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--

常见问题

Co-Diagnostics Inc的前五大股东是谁?

Co-Diagnostics Inc 的前五大股东如下:Mr. Richard S. Serbin

有多少机构持有Co-Diagnostics Inc(CODX)的股份?

截至2026Q1,共有75家机构持有Co-Diagnostics Inc的股份,合计持有的股份价值约为248.15K,占公司总股份的6.89%。与2025Q4相比,机构持股有所增加,增幅为-158736.00。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有